Therapeutic Effects of Rho Kinase Inhibitor on Experimental Diabetic Neuropathy

被引：0
|
作者：
Kanazawa, Yasushi
Utsunomiya, Kazunori
Ishizawa, Shou
Matoba, Keiichiro
Gojo, Atsushi
Yokota, Tamotsu
Kurata, Hideaki
Tajima, Naoko
Fujigasaki, Junko
机构：
来源：
DIABETES | 2009年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A228 / A228
页数：1
相关论文
共 50 条
  • [1] Suppression of Rho/Rho-Kinase Pathway in Diabetic Rats Provides a Therapeutic Effect on Diabetic Neuropathy
    Kanazawa, Yasushi
    Takahashi-Fujigasaki, Junko
    Taka-Bayashi, Naoko
    Ishibashi, Kumiko
    Ishizawa, Sho
    Matoba, Keiichiro
    Kawanami, Daiji
    Yokota, Tamotsu
    Utsunomiya, Kazunori
    DIABETES, 2012, 61 : A148 - A148
  • [2] Preventive and therapeutic effects of the selective Rho-kinase inhibitor fasudil on experimental autoimmune neuritis
    Pineda, Arnold Angelo M.
    Minohara, Motozumi
    Kawamura, Nobutoshi
    Matsushita, Takuya
    Yamasaki, Ryo
    Sun, Xiaojia
    Piao, Hua
    Shimokawa, Hiroaki
    Kira, Jun-ichi
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2011, 306 (1-2) : 115 - 120
  • [3] Therapeutic Potential of Experimental Autoimmune Encephalomyelitis by Fasudil, a Rho Kinase Inhibitor
    Yu, Jie-Zhong
    Ding, Jing
    Ma, Cun-Gen
    Sun, Chang-Hai
    Sun, Yi-Fu
    Lu, Chuan-Zhen
    Xiao, Bao-Guo
    JOURNAL OF NEUROSCIENCE RESEARCH, 2010, 88 (08) : 1664 - 1672
  • [4] Pharmacological characterization of a highly selective Rho kinase (ROCK) inhibitor and its therapeutic effects in experimental pulmonary hypertension
    Cantoni, Silvia
    Cavalli, Stefano
    Pastore, Fiorella
    Accetta, Alessandro
    Pala, Daniele
    Vaccaro, Fabio
    Cesari, Nicola
    De Logu, Francesco
    Nassini, Romina
    Villetti, Gino
    Facchinetti, Fabrizio
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 850 : 126 - 134
  • [5] POLYOL PATHWAY AND DIABETIC NEUROPATHY - SELECTIVE PREVENTIVE EFFECTS OF AN ALDOSE REDUCTASE INHIBITOR IN EXPERIMENTAL DIABETIC NEUROPATHY
    KAMIJO, M
    YAGIHASHI, S
    JAPANESE JOURNAL OF MEDICINE, 1991, 30 (06) : 629 - 630
  • [6] Therapeutic potentials of the Rho kinase inhibitor Fasudil in experimental autoimmune encephalomyelitis and the related mechanisms
    Yuqing Yan
    Jiezhong Yu
    Ye Gao
    Gajendra Kumar
    Minfang Guo
    Yijin Zhao
    Qingli Fang
    Huiyu Zhang
    Jingwen Yu
    Yuqiang Jiang
    Han-Ting Zhang
    Cun-Gen Ma
    Metabolic Brain Disease, 2019, 34 : 377 - 384
  • [7] Therapeutic potentials of the Rho kinase inhibitor Fasudil in experimental autoimmune encephalomyelitis and the related mechanisms
    Yan, Yuqing
    Yu, Jiezhong
    Gao, Ye
    Kumar, Gajendra
    Guo, Minfang
    Zhao, Yijin
    Fang, Qingli
    Zhang, Huiyu
    Yu, Jingwen
    Jiang, Yuqiang
    Zhang, Han-Ting
    Ma, Cun-Gen
    METABOLIC BRAIN DISEASE, 2019, 34 (02) : 377 - 384
  • [8] The selective Rho-kinase inhibitor Fasudil is protective and therapeutic in experimental autoimmune encephalomyelitis
    Sun, Xiaojia
    Minohara, Motozumi
    Kikuchi, Hitoshi
    Ishizu, Takaaki
    Tanaka, Masahito
    Piao, Hua
    Osoegawa, Manabu
    Ohyagi, Yasumasa
    Shimokawa, Hiroaki
    Kira, Jun-ichi
    JOURNAL OF NEUROIMMUNOLOGY, 2006, 180 (1-2) : 126 - 134
  • [9] Therapeutic effects of aldose reductase inhibitor on experimental diabetic neuropathy through synthesis/secretion of nerve growth factor
    Ohi, T
    Saita, K
    Furukawa, S
    Ohta, M
    Hayashi, K
    Matsukura, S
    EXPERIMENTAL NEUROLOGY, 1998, 151 (02) : 215 - 220
  • [10] RhoA/Rho kinase signaling in the spinal cord and diabetic painful neuropathy
    Ohsawa, Masahiro
    Kamei, Junzo
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 644 (1-3) : 1 - 4
12345